Fem-Dophilus® 60 Capsules (Shelf Stable).

Fem-Dophilus® 60 Capsules (Shelf Stable)

$44.99
Shipping calculated at checkout.

Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

Fem-Dophilus® does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77°F (25°C).

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Description

Fem-Dophilus® contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1® and Lactobacillus reuteri, RC-14®, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1® and RC-14® to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus® from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

Fem-Dophilus® does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77°F (25°C).

GR-1®/RC-14® and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1®/RC-14® probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

These Statements Have Not Been Evaluated By The Food And Drug Administration. These Products Are Not Intended To Diagnose, Treat, Cure, Or Prevent Any Disease.

Brio-Medical Is The Owner And Operator Of BrioMedicalEssentials.Com. Brio-Medical Essentials Is Authorized To Sell Standard Process Products, But Is Not A Partner, Franchisor, Joint Venturer, Agent, Or Employee Of Standard Process Inc.